Li-Teh Liu , Po-Chih Chen , Chen-Hsuan Lin , Shi-Ya Huang , Chun-Hong Chen , Ching-Yi Tsai , Ping-Chang Lin , Cyuan-Ya Yang , Jih-Jin Tsai
{"title":"Performance comparison of two dengue NS1 rapid diagnostic tests against RT-PCR: Sensitivity and specificity across infections and timeframes","authors":"Li-Teh Liu , Po-Chih Chen , Chen-Hsuan Lin , Shi-Ya Huang , Chun-Hong Chen , Ching-Yi Tsai , Ping-Chang Lin , Cyuan-Ya Yang , Jih-Jin Tsai","doi":"10.1016/j.jiph.2025.102919","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Dengue virus (DENV) is a mosquito-borne flavivirus that remains a global public health threat, particularly in tropical regions where it is endemic. Accurate and timely diagnosis is critical for optimal patient care and effective outbreak containment. While reverse transcription-polymerase chain reaction (RT-PCR) remains the gold standard for dengue diagnosis, nonstructural protein 1 (NS1) rapid diagnostic tests (RDTs) offer a more accessible alternative. However, their performance may vary with infection type, serotype, and the timing of sample collection.</div></div><div><h3>Methods</h3><div>We evaluated the diagnostic performance of two NS1 RDTs, Abbott NS1 and PBF NS1, against RT-PCR as the reference standard. A total of 183 dengue-positive and 40 dengue-negative samples were obtained during the 2023 dengue outbreak in Kaohsiung, Taiwan. Sensitivity, specificity, and predictive values were comprehensively assessed based on infection type, serotype, and post-symptom onset (PSO) intervals. Additionally, we analyzed the diagnostic benefits of combining NS1 detection with anti-DENV IgM serology.</div></div><div><h3>Results</h3><div>Abbott NS1 exhibited notably higher sensitivity (87.4 % vs. 83.1 %) and specificity (100 % vs. 97.5 %) compared to PBF NS1, though the differences were not statistically significant. Sensitivity varied by PSO, with Abbott NS1 achieving significantly higher sensitivity beyond three days (97.4 % vs. 76.9 %, P = 0.034). In secondary infections, Abbott NS1 outperformed PBF NS1 (86.8 % vs. 79.2 %). When combined with anti-DENV IgM serology, both RDTs demonstrated improved diagnostic sensitivity, particularly in secondary infections.</div></div><div><h3>Conclusions</h3><div>Our findings underscore the importance of context-specific diagnostic tools. Combining NS1 antigen detection with IgM serology enhances diagnostic accuracy. While Abbott NS1 demonstrated slightly better performance, PBF NS1 remains a viable and non-inferior alternative.</div></div>","PeriodicalId":16087,"journal":{"name":"Journal of Infection and Public Health","volume":"18 11","pages":"Article 102919"},"PeriodicalIF":4.0000,"publicationDate":"2025-08-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Infection and Public Health","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1876034125002680","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Dengue virus (DENV) is a mosquito-borne flavivirus that remains a global public health threat, particularly in tropical regions where it is endemic. Accurate and timely diagnosis is critical for optimal patient care and effective outbreak containment. While reverse transcription-polymerase chain reaction (RT-PCR) remains the gold standard for dengue diagnosis, nonstructural protein 1 (NS1) rapid diagnostic tests (RDTs) offer a more accessible alternative. However, their performance may vary with infection type, serotype, and the timing of sample collection.
Methods
We evaluated the diagnostic performance of two NS1 RDTs, Abbott NS1 and PBF NS1, against RT-PCR as the reference standard. A total of 183 dengue-positive and 40 dengue-negative samples were obtained during the 2023 dengue outbreak in Kaohsiung, Taiwan. Sensitivity, specificity, and predictive values were comprehensively assessed based on infection type, serotype, and post-symptom onset (PSO) intervals. Additionally, we analyzed the diagnostic benefits of combining NS1 detection with anti-DENV IgM serology.
Results
Abbott NS1 exhibited notably higher sensitivity (87.4 % vs. 83.1 %) and specificity (100 % vs. 97.5 %) compared to PBF NS1, though the differences were not statistically significant. Sensitivity varied by PSO, with Abbott NS1 achieving significantly higher sensitivity beyond three days (97.4 % vs. 76.9 %, P = 0.034). In secondary infections, Abbott NS1 outperformed PBF NS1 (86.8 % vs. 79.2 %). When combined with anti-DENV IgM serology, both RDTs demonstrated improved diagnostic sensitivity, particularly in secondary infections.
Conclusions
Our findings underscore the importance of context-specific diagnostic tools. Combining NS1 antigen detection with IgM serology enhances diagnostic accuracy. While Abbott NS1 demonstrated slightly better performance, PBF NS1 remains a viable and non-inferior alternative.
期刊介绍:
The Journal of Infection and Public Health, first official journal of the Saudi Arabian Ministry of National Guard Health Affairs, King Saud Bin Abdulaziz University for Health Sciences and the Saudi Association for Public Health, aims to be the foremost scientific, peer-reviewed journal encompassing infection prevention and control, microbiology, infectious diseases, public health and the application of healthcare epidemiology to the evaluation of health outcomes. The point of view of the journal is that infection and public health are closely intertwined and that advances in one area will have positive consequences on the other.
The journal will be useful to all health professionals who are partners in the management of patients with communicable diseases, keeping them up to date. The journal is proud to have an international and diverse editorial board that will assist and facilitate the publication of articles that reflect a global view on infection control and public health, as well as emphasizing our focus on supporting the needs of public health practitioners.
It is our aim to improve healthcare by reducing risk of infection and related adverse outcomes by critical review, selection, and dissemination of new and relevant information in the field of infection control, public health and infectious diseases in all healthcare settings and the community.